National Malaria Strategic Plan (NMSP) of Myanmar: 2016 – 2020

Note: A more recent NMSP is available. View it here (link). 

The “National Strategic Plan (NSP) for Intensifying Malaria Control and Accelerating Progress towards Malaria Elimination 2016-2020” has been developed under the leadership of National Malaria Control Programme (NMCP) with technical support from WHO. 

Vision: A Malaria Free Myanmar by 2030

Mission: The National Malaria Control Programme (NMCP) of the Ministry of Health and Sports of the government of Myanmar aims to achieve malaria elimination (‘zero indigenous transmission’ and ‘zero malaria deaths’) by ensuring equitable and universal access to effective preventive and curative services to all ‘at risk populations’ in coordination with the efforts of all communities, national and international non-governmental organizations, private sector stakeholders, United Nations agencies and financial partners. Achieving the vision of ‘A Malaria Free Myanmar’ will contribute significantly to poverty alleviation as malaria is most prevalent in the poorest segment of the population: those living or spending time in remote forested areas including mobile populations and migrants.

Goals: This is a five-year strategy to reduce malaria morbidity and mortality by 85% and 75% respectively by 2020 relative to 2015 baseline figures. In States/Regions where malaria transmission has been interrupted, the goal is to maintain malaria-free status and prevent re- establishment of local transmission.

Achieving these goals will put Myanmar on the path to eliminate Plasmodium falciparum malaria by 2025 (in line with the urgent action required against multidrug resistance) and all malaria from Myanmar by 2030.

Objectives:

1. To reduce reported incidence of malaria to less than 1 case per 1,000 population in all States/Regions by 2020.
2. To interrupt transmission of falciparum malaria in at least 5 States/Regions by 2020 (Target States/Regions: Bago, Magway, Yangon, Mon, Mandalay).
3. To prevent the emergence of multi-ACT resistant P. falciparum in Myanmar.
4. To prevent the re-establishment of malaria in areas where transmission has been interrupted.